Learn more

UNIV YORK

Overview
  • Total Patents
    694
  • GoodIP Patent Rank
    10,377
  • Filing trend
    ⇩ 37.0%
About

UNIV YORK has a total of 694 patent applications. It decreased the IP activity by 37.0%. Its first patent ever was published in 1971. It filed its patents most often in United Kingdom, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are INVITROGEN CORP, FEDERALNOE GOSUDARSTVENNOE BYUDZHETNOE NAUCHNOE UCHREZHDENIE INST EKSPERIMENTALNOJ MEDITSINY FGBNU I and UNIV KOBE NAT UNIV CORP.

Patent filings per year

Chart showing UNIV YORKs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Graham Ian 33
#2 Clark James Hanley 32
#3 Lim Eng-Kiat 23
#4 Tonon Thierry 20
#5 Budarin Vitaliy Lvovich 18
#6 Lim Eng Kiat 17
#7 Graham Ian Alexander 17
#8 Bowles Dianna Joy 16
#9 Bowles Dianna 16
#10 Smith Stephen 15

Latest patents

Publication Filing date Title
GB202016889D0 Secure communication
GB202015681D0 Methods and apparatus for coherent signal transmission
GB202015564D0 Mutated plant
GB202011442D0 Isolation of cannabinoids using mesoporous materials
GB202005726D0 Organometallic gels
GB202001106D0 Light modulator with variable transparency
GB202000378D0 Lignin depolymerisation
GB201918010D0 Acoustic measurements
GB201907512D0 Compounds containing a quaternary centre
GB201907130D0 Dehydrogenase and chytochrome P450 polypeptides
GB201906790D0 Sensor system and fluid flow pathway system therefor
GB201903515D0 Methods and apparatus for coherent signal amplification and detection
GB201901060D0 Service cell selection
WO2019145693A1 Inhibitory agent
GB201820267D0 Proof-of-work for blockchain applications
GB201818171D0 A series of catalysts for the hyperpolarisation of substrates including pyruvaten through polarisation transfer from protons derived from parahydrogen
GB201816820D0 Diagnostic method
GB201813721D0 Treatment of urinary tract disorders
GB201812657D0 Inhibitory agent
EP3658945A2 Hyperpolarising substrates through relayed transfer via systems containing exchangeable protons